Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1989
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C01BC03
|
| gptkbp:contraindication |
hypotension
bradycardia cardiogenic shock severe heart failure |
| gptkbp:drugClass |
antiarrhythmic
|
| gptkbp:excretion |
urine
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:propafenone
|
| gptkbp:halfLife |
2-10 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Rhythmol
|
| gptkbp:interactsWith |
gptkb:warfarin
gptkb:digoxin beta blockers cimetidine amiodarone |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:GSK
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness fatigue metallic taste |
| gptkbp:usedFor |
gptkb:arrhythmia
gptkb:atrial_fibrillation ventricular arrhythmias |
| gptkbp:bfsParent |
gptkb:Purdue_Pharma
|
| gptkbp:bfsLayer |
6
|